Jefferies Group’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-164,765
Closed -$5.66M 2647
2014
Q4
$5.66M Buy
164,765
+114,744
+229% +$3.74M 0.03% 392
2014
Q3
$1.49M Sell
50,021
-101,963
-67% -$2.16M 0.01% 834
2014
Q2
$3.05M Buy
151,984
+51,166
+51% +$1.17M 0.03% 495
2014
Q1
$2.74M Buy
100,818
+56,686
+128% +$1.5M 0.03% 497
2013
Q4
$915K Buy
+44,132
New +$832K 0.01% 874
2013
Q3
Sell
-223
Closed -$4K 2403
2013
Q2
$4K Buy
+223
New +$3.56K ﹤0.01% 1794

Other funds holding AUXL

Jefferies Group's AUXL Position: Q1 2015 in Review

Jefferies Group sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 164,765 shares — an estimated $5.66M sold.

Jefferies Group first reported a position in AUXL in Q2 2013 and held it in 6 quarters. The position peaked at $5.66M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Jefferies Group reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Jefferies Group sold 164,765 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $5.66M.
  • Jefferies Group first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Jefferies Group's AUXILIUM PHARAMCEUTICALS INC position peaked at $5.66M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Jefferies Group's 13F filing for Q1 2015, filed 18 May 2015.